Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Androgen Receptor-Reduced Sensitivity Is Associated With Increased Mortality and Poorer Glycaemia in Men With Type 2 Diabetes Mellitus: A Prospective Cohort Study Publisher



Heald AH1, 2 ; Yadegar Far G1, 3 ; Livingston M4 ; Fachim H1, 2 ; Lunt M1 ; Narayanan RP5 ; Siddals K1 ; Moreno G6 ; Jones R1, 7 ; Malipatil N1, 2 ; Rutter M1, 8 ; Gibson M1, 2 ; Donn R1 ; Hackett G9 Show All Authors
Authors
  1. Heald AH1, 2
  2. Yadegar Far G1, 3
  3. Livingston M4
  4. Fachim H1, 2
  5. Lunt M1
  6. Narayanan RP5
  7. Siddals K1
  8. Moreno G6
  9. Jones R1, 7
  10. Malipatil N1, 2
  11. Rutter M1, 8
  12. Gibson M1, 2
  13. Donn R1
  14. Hackett G9
  15. Jones H10, 11
Show Affiliations
Authors Affiliations
  1. 1. Manchester Academic Health Sciences Centre, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom
  2. 2. Department of Diabetes and Endocrinology, Salford Royal Hospital, Salford, United Kingdom
  3. 3. Heart Failure Research Centre & Epidemiology, Biostatics Department School of Public Heath, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Department of Clinical Biochemistry, Black Country Pathology Services, Walsall Manor Hospital, Walsall, United Kingdom
  5. 5. Institute for Ageing and Chronic Diseases, University of Liverpool, Liverpool, United Kingdom
  6. 6. General Directorate for Quality and Health Education, Mexico City, Mexico
  7. 7. Besins Healthcare, London, United Kingdom
  8. 8. Diabetes Centre Manchester University Nhs Foundation Trust, Manchester, United Kingdom
  9. 9. Department of Sexual Urology, Heartlands Hospital, Birmingham, United Kingdom
  10. 10. Centre for Diabetes and Endocrinology, Barnsley Hospital, Barnsley, United Kingdom
  11. 11. Department of Oncology and Metabolism, University of Sheffield, Sheffield, United Kingdom

Source: Cardiovascular Endocrinology and Metabolism Published:2020


Abstract

Introduction Hypogonadism is associated with poorer glycaemic outcomes/increased all-cause and cardiovascular morbidity/mortality in type 2 diabetes mellitus (T2DM). Increasing CAG repeat number within exon-1 of the androgen receptor (AR) gene is associated with increased AR resistance/insulin resistance. Methods We determined in a long-term 14-year follow-up cohort of 423 T2DM Caucasian men, the association between baseline androgen status/CAG repeat number (by PCR then Sequenom sequencing) and metabolic/cardiovascular outcomes. Results Metabolic outcomes: Lower total testosterone was associated with higher BMI (kg/m2) at 14-year-follow-up: regression coefficient -0.30 (95% confidence interval -0.445 to -0.157), P = 0.0001. The range of CAG repeat number was 9-29 repeats. Higher CAG repeat number in exon-1 of the AR gene was associated with higher follow-up HbA1c2016 - each unit increase in CAG repeat-associated with an increment of 0.1% in HbA1C2016 (P = 0.04), independent of baseline testosterone. Cardiovascular outcomes and mortality: At an average of 14-year-follow-up, 55.8% of hypogonadal men had died vs 36.1% of eugonadal men (P = 0.001). There was a 'u' shaped relation between number of CAG repeats and mortality. Twenty-one CAG repeats were associated with an up to nearly 50% lower mortality rate than <21 CAG repeats and >21 CAG repeats - independent of baseline testosterone level. Conclusion A higher number of CAG repeats at the AR gene associates with higher future HbA1c. There was a 'u' shaped relation between CAG repeat number and mortality rate. Determination of CAG repeat number may become part of assessment of androgen status/its consequences for men with T2DM. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Related Docs
Experts (# of related papers)